Clinical Trial: A Study of Flovent in Patients With Eosinophilic Esophagitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis

Brief Summary: The purpose of this study is to test the effects (both good and bad) of swallowed fluticasone propionate (Flovent), in subjects with eosinophilic esophagitis (EE).